The importance of circulating tumor DNA in patients with primary CNS lymphoma

Won Seog Kim, MD, PhD, Sungkyunkwan University School of Medicine, Seoul, South Korea, discusses the importance of plasma circulating tumor DNA (ctDNA) in patients with primary central nervous system (CNS) lymphoma and applications of ctDNA in a clinical setting. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.